Viewing Study NCT00118768


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2026-01-01 @ 10:22 AM
Study NCT ID: NCT00118768
Status: COMPLETED
Last Update Posted: 2009-03-02
First Post: 2005-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module